[1] 肖爽, 朱以诚. 脑卒中的性别差异:流行病学、危险因素、治疗及预后 [J]. 中国神经免疫学和神经病学杂志, 2020, 27(1): 57-60. [2] WANG L, CHENG Q, HU T, et al. Impact of stress hyperglycemia on early neurological deterioration in acute ischemic stroke patients treated with intravenous thrombolysis [J]. Front Neurol, 2022, 13: 870872. [3] TSUI B, CHEN I E, NOUR M, et al. Perfusion collateral index versus hypoperfusion intensity ratio in assessment of collaterals in patients with acute ischemic stroke [J]. AJNR Am J Neuroradiol, 2023, 44(11): 1249-1255. [4] SENERS P, TURC G, LION S, et al. Relationships between brain perfusion and early recanalization after intravenous thrombolysis for acute stroke with large vessel occlusion [J]. J Cereb Blood Flow Metab, 2020, 40(3): 667-677. [5] HUANG Y W, YIN X S, LI Z P. Association of the systemic immune-inflammation index (SII) and clinical outcomes in patients with stroke: a systematic review and meta-analysis [J]. Front Immunol, 2022, 13: 1090305. [6] 钟迪, 张舒婷, 吴波. 《中国急性缺血性脑卒中诊治指南2018》解读 [J]. 中国现代神经疾病杂志, 2019, 19(11): 897-901. [7] ALAWNEH J A, MOUSTAFA R R, BARON J C. Hemodynamic factors and perfusion abnormalities in early neurological deterioration [J]. Stroke, 2009, 40(6): e443-e450. [8] FAIZY T D, KABIRI R, CHRISTENSEN S, et al. Perfusion imaging-based tissue-level collaterals predict ischemic lesion net water uptake in patients with acute ischemic stroke and large vessel occlusion [J]. J Cereb Blood Flow Metab, 2021, 41(8): 2067-2075. [9] VAN HORN N, BROOCKS G, KABIRI R, et al. Cerebral hypoperfusion intensity ratio is linked to progressive early edema formation [J]. J Clin Med, 2022, 11(9):2373. [10] WINKELMEIER L, HEIT J J, ADUSUMILLI G, et al. Hypoperfusion intensity ratio is correlated with the risk of parenchymal hematoma after endovascular stroke treatment [J]. Stroke, 2023, 54(1): 135-143. [11] MAI¨ER B, TSAI A S, EINHAUS J F, et al. Neuroimaging is the new "spatial omic": multi-omic approaches to neuro-inflammation and immuno-thrombosis in acute ischemic stroke [J]. Semin Immunopathol, 2023, 45(1): 125-143. [12] WANG N, YANG Y, QIU B, et al. Correlation of the systemic immune-inflammation index with short- and long-term prognosis after acute ischemic stroke [J]. Aging (Albany NY), 2022, 14(16): 6567-6578. [13] YANG Y, CUI T, BAI X, et al. Association between systemic immune-inflammation index and symptomatic intracranial hemorrhage in acute ischemic stroke patients undergoing endovascular treatment [J]. Curr Neurovasc Res, 2022, 19(1): 83-91. [14] HUANG L. Increased systemic immune-inflammation index predicts disease severity and functional outcome in acute ischemic stroke patients [J]. Neurologist, 2023, 28(1): 32-38. [15] DHANESHA N, PATEL R B, DODDAPATTAR P, et al. PKM2 promotes neutrophil activation and cerebral thromboinflammation: therapeutic implications for ischemic stroke [J]. Blood, 2022, 139(8): 1234-1245. [16] KOUPENOVA M, CLANCY L, CORKREY H A, et al. Circulating platelets as mediators of immunity, inflammation, and thrombosis [J]. Circ Res, 2018, 122(2): 337-351. [17] WINKLEWSKI P J, RADKOWSKI M, DEMKOW U. Cross-talk between the inflammatory response, sympathetic activation and pulmonary infection in the ischemic stroke [J]. J Neuroinflammation, 2014, 11: 213. [18] MERGENTHALER P, LINDAUER U, DIENEL G A, et al. Sugar for the brain: the role of glucose in physiological and pathological brain function [J]. Trends Neurosci, 2013, 36(10): 587-597. |